Somatostatin/GRIH Antibody

Somatostatin (growth hormone release-inhibiting factor) inhibits the release of somatotropin (growth hormone). A synthetic analog known as octreotide or SMS 201-995 is available under the name Sandostatin (Novartis). It is used for the treatment of a variety of disorders including acromegaly and the symptomatic treatment of carcinoid tumors and vasoactive intestinal peptide tumors.